production

production


Oligonucleotide

Apextide's oligonucleotide technology platform is equipped with the most advanced technology equipment, including Cytiva OligoSynt/OligoPilot solid-phase synthesizers and AKTA Avant/Process purification equipment, capable of covering production scales from mg to kg. These platforms can provide customers with a full range of CRDMO services, covering the development and production of API from preclinical to commercial stages.

What We Manufacture:

Conjugations

Conjugations

Modifications

Modifications

Phosphorothioate, 2’-F, 2’-OMe, 2'-OMOE, 5-methylcytosine, LNA, PMO etc.

Conjugations

Conjugations

3'-end or 5'-end with GalNAc, triphosphate, cholesterol, saccharides, peptides, maleimide etc.

peptide

Apextide provides comprehensive and highly personalized peptide synthesis solutions for life science research and innovative drug development with superior technical strength and excellent scientific research experience. With cutting-edge synthesis equipment and an experienced professional chemistry team, we are committed to meeting the diverse needs of our customers for high-quality, high-purity peptide products in biomedicine and drug discovery research through flexible customized services such as peptide modification, peptide conjugate synthesis and peptide customization, and becoming a reliable partner to promote life science innovation.

What We Manufacture:

Modifications

Modifications

Linear peptide, Cyclic peptide, Tree peptide, Stapled peptide, etc.

Modifications

Modifications

Phosphorylation, Methylation, Acetylatio, Amidation etc.

Conjugations

Conjugations

PDC,PPMO, POC etc.

Capabilities by the Numbers

70 +

experienced scientists and engineers with Ph.D. and masters degree

30 +

project

6-8 months from

6-8 months from synthesis to tox batch release

1000 + kg/yea

capacity